Angels for Change, the nation’s only nonprofit, patient advocacy organization dedicated to ending drug shortages, announces expansion of their team to three employees with the addition of a Chief Operating Officer (COO).
Thank you to the Journal of Clinical Pathways for interviewing Chief Change Maker, Laura Bray at the 2024 National Comprehensive Cancer Network annual conference.
Science Friday took a deep dive into the complexities of drug shortages and the patient harm they create.
Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.
“After listening to families and many other organizations at the center of this community, including the Children’s Oncology Group and Angels for Change, we embarked on an aggressive development path to bring a new recombinant erwinia asparaginase option to market, one that will be manufactured under the highest quality standards and provide a reliable supply to meet the needs of our patients.”
We are proud and grateful we could help these Warrior families obtain the life-saving drugs they needed to successfully complete their child’s chemotherapy treatment. Yet we have always maintained our goal is that no parent or patient should ever have to hear, and no doctor should ever have to say, “We don’t have the life-saving drug you need.”
